AAAAAA

   
Results: 1-11 |
Results: 11
RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION
Authors: CARLENS S RINGDEN O ASCHAN J HAGGLUND H LJUNGMAN P MATTSSON J REMBERGER M
Citation: S. Carlens et al., RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION, Clinical transplantation, 12(2), 1998, pp. 84-92
RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Authors: CARLENS S RINGDEN O REMBERGER M LONNQVIST B HAGGLUND H KLAESSON S MATTSSON J SVAHN BM WINIARSKI J LJUNGMAN P ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J CARLENS S HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Bone marrow transplantation, 21(1), 1998, pp. 43-49
A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT
Authors: HAGGLUND H RINGDEN O OHMAN S REMBERGER M CARLENS S MATTSSON J
Citation: H. Hagglund et al., A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT, Bone marrow transplantation, 21, 1998, pp. 113-113
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES, Bone marrow transplantation, 21, 1998, pp. 114-114
BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS
Authors: HENTSCHKE P HAGGLUND H MATTSSON J CARLENS S LONNQVIST B LJUNGMAN P ASCHAN J RINGDEN O
Citation: P. Hentschke et al., BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21, 1998, pp. 326-326
LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S ASCHAN J REMBERGER M RINGDEN O
Citation: S. Carlens et al., LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 414-414
CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS
Authors: KLAESSON S HAGGLUND H LJUNGMAN P CARLENS S MATTSSON J REMBERGER M SPARRELID E WINIARSKI J RINGDEN O
Citation: S. Klaesson et al., CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 415-415
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E ELMHORNROSENBORG A SVAHN BM LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES, Transplantation, 66(5), 1998, pp. 620-625
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H CARLENS S LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Transplantation proceedings, 29(7), 1997, pp. 3145-3146
FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H LJUNGMAN P
Citation: S. Carlens et al., FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Transplantation proceedings, 29(7), 1997, pp. 3147-3149
Risultati: 1-11 |